CFGS
MURA

Concourse Financial Group Securities’s Mural Oncology MURA Stock Holding History

Concourse Financial Group Securities’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1
Closed -$3 – 2339
2024
Q2 		$3 Hold
1
– – ﹤0.01% 2294
2024
Q1 		$4 Hold
1
– – ﹤0.01% 2301
2023
Q4 		$5 Buy
+1
New +$4 ﹤0.01% 2271

Other funds holding MURA

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $333M AUM 102.25% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

Concourse Financial Group Securities's MURA Position: Q3 2024 in Review

Concourse Financial Group Securities sold out of Mural Oncology (MURA) in Q3 2024, closing a stake of 1 share — an estimated $3 sold.

Concourse Financial Group Securities first reported a position in MURA in Q4 2023 and held it in 3 quarters. The position peaked at $5 in Q4 2023. 74 funds tracked by Wall St. Rank hold MURA as of Q3 2024.

  • Concourse Financial Group Securities reported no remaining Mural Oncology position as of Q3 2024 after selling out during the quarter.
  • Concourse Financial Group Securities sold 1 Mural Oncology share in Q3 2024, an estimated $3.
  • Concourse Financial Group Securities first reported a position in Mural Oncology in Q4 2023 and held it in 3 quarters.
  • Concourse Financial Group Securities's Mural Oncology position peaked at $5 in Q4 2023.
  • 74 funds tracked by Wall St. Rank held Mural Oncology as of Q3 2024.

Based on Concourse Financial Group Securities's 13F filing for Q3 2024, filed 10 Oct 2024.